文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

急诊科丙泊酚中度与深度镇静的目标水平比较:程序性遗忘与呼吸抑制的随机临床试验

Randomized Clinical Trial Comparing Procedural Amnesia and Respiratory Depression Between Moderate and Deep Sedation With Propofol in the Emergency Department.
PubMed 文献 · Acad Emerg Med · 2018-09-24
一句话结论急诊成人丙泊酚镇静中,目标中度镇静相比目标深度镇静总不良呼吸事件更少且遗忘无差异,但目标水平常不能可靠达到。

这项前瞻性随机临床试验纳入107例计划接受丙泊酚深度镇静的急诊成人患者,随机分为目标中度镇静组(54例)与目标深度镇静组(53例)。目标中度镇静组仅50%达到中度镇静,目标深度镇静组77%达到深度镇静。目标中度镇静组丙泊酚中位总剂量较低(1.4 mg/kg vs 1.8 mg/kg),图像回忆率(4.7% vs 3.8%,p=0.73)与识别率(61.1% vs 55%,p=0.52)无差异,任何不良呼吸事件发生率无差异(41% vs 42%,p=0.77),但目标中度镇静组不良呼吸事件总数降低23%(p=0.01,95%CI -0.41至-0.04)。患者疼痛、满意度、回忆VAS评分及操作难度、成功率均相似。作者认为目标中度镇静可提供足够遗忘且需要支持性气道干预更少。

要点

  • 目标中度镇静组仅50%达到中度镇静,目标深度镇静组77%达到深度镇静,目标水平不能可靠实现。
  • 目标中度镇静组丙泊酚中位总剂量1.4 mg/kg,低于目标深度镇静组的1.8 mg/kg。
  • 任何不良呼吸事件发生率两组无差异:目标中度镇静组41% vs 目标深度镇静组42%(p=0.77)。
  • 目标中度镇静组不良呼吸事件总数较目标深度镇静组降低23%(p=0.01,95%CI -0.41至-0.04)。
  • 图像回忆率(4.7% vs 3.8%,p=0.73)与识别率(61.1% vs 55%,p=0.52)两组无差异。

适用人群与场景

  • 计划接受丙泊酚深度镇静的同意参与的急诊成人患者,研究时间为2015年3月5日至2017年5月24日。

诊断标准与关键阈值

  • 使用美国麻醉医师学会(ASA)定义区分中度镇静与深度镇静目标水平。
  • 亚临床呼吸抑制定义为SaO2≤91%、ETCO2变化≥10 mm Hg或任何时间ETCO2缺失。
  • 呼吸抑制合并需要支持性气道操作定义为不良呼吸事件。

处置流程与药物剂量

  • 丙泊酚中位总剂量:目标中度镇静组1.4 mg/kg(95%CI 1.3-1.6,IQR=1),目标深度镇静组1.8 mg/kg(95%CI 1.6-2.0,IQR=0.9)。
  • 持续监测生命体征、警觉/镇静观察者评估(OAAS)评分、呼气末二氧化碳(ETCO2)及支持性气道操作需求(球囊面罩使用、体位调整、刺激诱发呼吸)。
  • 操作前3分钟开始每30秒展示标准化图像直至操作后恢复基线,镇静后10分钟评估图像回忆与识别。

红旗征与不能漏的情况

  • 需要支持性气道操作(球囊面罩使用、体位调整、刺激诱发呼吸)的呼吸抑制事件。

研究设计与关键结果

  • 前瞻性随机临床试验纳入107例急诊成人患者,目标中度镇静组54例,目标深度镇静组53例。
  • 目标中度镇静组50%达到中度镇静、50%达到深度镇静;目标深度镇静组77%达到深度镇静、23%达到中度镇静。
  • 操作中中位OAAS评分目标中度镇静组2.4 vs 目标深度镇静组2.8,最低OAAS两组均为2。
  • 图像回忆率目标中度镇静组4.7% vs 目标深度镇静组3.8%(p=0.73),图像识别率61.1% vs 55%(p=0.52)。
  • 任何不良呼吸事件发生率目标中度镇静组41% vs 目标深度镇静组42%(p=0.77,95%CI差值-0.12至0.24)。
  • 不良呼吸事件总数目标中度镇静组较目标深度镇静组降低23%(p=0.01,95%CI -0.41至-0.04)。
  • 患者疼痛、满意度、回忆VAS评分及操作难度、操作成功率两组相似。

证据类型、等级与局限

  • 证据类型:前瞻性随机临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为目标中度镇静可提供足够遗忘且需要支持性气道干预更少,尽管目标水平常不能可靠达到。
  • 目标中度镇静组丙泊酚中位总剂量1.4 mg/kg低于目标深度镇静组1.8 mg/kg。
  • 目标中度镇静组不良呼吸事件总数较目标深度镇静组降低23%,任何不良呼吸事件发生率两组无差异。
  • 图像回忆与识别率两组无差异,患者疼痛、满意度、回忆VAS评分及操作难度、成功率相似。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The objective was to determine if there is a difference in procedural amnesia and adverse respiratory events (AREs) between the target sedation levels of moderate (MS) and deep (DS) procedural sedation.

METHODS: This was a prospective, randomized clinical trial of consenting adult patients planning to undergo DS with propofol between March 5, 2015, and May 24, 2017. Patients were randomized to a target sedation level of MS or DS using the American Society of Anesthesiologist's definitions. Drug doses, vital signs, observer's assessment of alertness/sedation (OAAS) score, end-tidal CO2 (ETCO2 ), and the need for supportive airway maneuvers (SAMs; bag-valve mask use, repositioning, and stimulation to induce respirations) were monitored continuously. A standardized image was shown every 30 seconds starting 3 minutes before the procedure continuing until the patient had returned to baseline after the procedure. Recall and recognition of images were assessed 10 minutes after the sedation. Subclinical respiratory depression (RD) was defined as SaO2 ≤ 91%, change in ETCO2 ≥ 10 mm Hg, or absent ETCO2 at any time. The occurrence of RD with a SAM was defined as an ARE. Patient satisfaction, pain, and perceived recollection and physician assessment of procedure difficulty were collected using visual analog scales (VASs). Data were analyzed with descriptive statistics and Wilcoxon rank-sum test.

RESULTS: A total of 107 patients were enrolled: 54 randomized to target MS and 53 to DS. Of the patients randomized to target MS, 50% achieved MS and 50% achieved DS. In the target DS group, 77% achieved DS and 23% achieved MS. The median total propofol dose (mg/kg) was lower in the MS group: MS 1.4 (95% confidence interval [CI] = 1.3-1.6, IQR = 1) versus DS 1.8 (95% CI = 1.6-2.0, IQR = 0.9). There were no differences in median OAAS during the procedure (MS 2.4 and DS 2.8), lowest OAAS (MS 2 and DS 2), percentage of images recalled (MS 4.7% vs. DS 3.8%, p = 0.73), or percentage of images recognized (MS 61.1% vs. DS 55%, p = 0.52). In the MS group, 41% patients had any AREs compared to 42% in the DS group (p = 0.77, 95% CI difference = -0.12 to 0.24). The total number of AREs was 23% lower in the MS group (p = 0.01, 95% CI = -0.41 to -0.04). There was no difference in patient-reported pain, satisfaction, or recollection VAS scores. Provider's rating of procedural difficulty and procedural success were similar in both groups.

CONCLUSIONS: Targeting MS or DS did not reliably result in the intended sedation level. Targeting MS, however, resulted in a lower rate of total AREs and fewer patients had multiple AREs with no difference in procedural recall. As seen in previous reports, patients who achieved MS had less AREs than those who achieved DS. Our study suggests that a target of MS provides adequate amnesia with less need for supportive airway interventions than a target level of DS, despite the fact that it often does not result in intended sedation level.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Schick A, Driver B, Moore JC, et al. Randomized Clinical Trial Comparing Procedural Amnesia and Respiratory Depression Between Moderate and Deep Sedation With Propofol in the Emergency Department. Acad Emerg Med. 2018. PMID: 30098230. doi:10.1111/acem.13548

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。